en

PRODUCT DETAIL

Gefitinib Mylan 250 mg filmom obalené tablety

Code 9564C
MA number EU/1/18/1321/002
Product Form: tbl flm 30x1x250 mg (blis.PVC/PVDC/Al-jednotk.bal.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EB Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors
L01EB01 Gefitinib
Shelf life: 24
Container: blister PVC/PVDC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 27.09.2018
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 11.07.2023
eu-flag.png sk-flag.png